FDA Commissioner Marty Makary said the agency may fast-track new drugs from pharmaceutical companies that “equalize” the cost ...

"For decades, menopause has been overlooked in both clinical research and health care policy, largely because it affects ...

There’s a new wave of interest in improving menopause care in the United States. It’s in books, on podcasts and dominating social media hashtags – and it’s even generating new legislation across more ...